RxDoctor Payments DataLook up a doctor →

Vincent Ma, MD

Hematology & Oncology · Madison, WINPI 1437530722

Payments from drug & device makers

$1,155,837in general payments, 2019–2025

Across 363 payments — averaging $3184.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Y-mabs Therapeutics, Inc.$438K
  • Seagen Inc.$281K
  • Regeneron$267K
  • Merck$66K
  • Pfizer$57K
  • Delcath Systems$18K
  • plus $28K from 6 others
$1,909in research payments, 2019–2025

Across 10 payments — averaging $190.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$2K

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,155,837 in reported general payments places this provider in the 90th percentile of 248 hematology & oncology providers in Wisconsin.

See all hematology & oncology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$37,409
Medicare patients
122
Services billed
401

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Madison

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →